Display Settings:

Format

Send to:

Choose Destination
    J Extra Corpor Technol. 2003 Dec;35(4):339-45.

    Use of aprotinin in patients undergoing deep hypothermic circulatory arrest: a review.

    Source

    University of Kansas Hospital, Kansas City, Kansas 66160, USA.

    Abstract

    Hemostatic derangements continue to be a major clinical challenge during thoracic aortic surgery using deep hypothermic circulatory arrest despite advances in surgical and pharmacologic therapy. Aprotinin, a broad-based, nonspecific serine protease inhibitor has been advocated for prophylactic use in cardiac surgery to decrease perioperative blood loss and blood transfusions. Its efficacy has been documented in several studies throughout the United States and Europe. Currently, aprotinin is advocated for use in patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery. A review of current studies is provided that examines aprotinin usage under deep hypothermic circulatory arrest.

    PMID:
    14979426
    [PubMed - indexed for MEDLINE]

    LinkOut - more resources

    Molecular Biology Databases

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk